Chronic hypertension resident survival guide: Difference between revisions
Line 244: | Line 244: | ||
==Treatment== | ==Treatment== | ||
Shown below is an algorithm summarizing the treatment of | Shown below is an algorithm summarizing the treatment of hypertension based on the 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8), ESH/ESC guidelines for the management of arterial hypertension, and the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.<ref name="pmid14656957">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. | journal=Hypertension | year= 2003 | volume= 42 | issue= 6 | pages= 1206-52 | pmid=14656957 | doi=10.1161/01.HYP.0000107251.49515.c2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14656957 }} </ref><ref name="Mancia-2013">{{Cite journal | last1 = Mancia | first1 = G. | last2 = Fagard | first2 = R. | last3 = Narkiewicz | first3 = K. | last4 = Redán | first4 = J. | last5 = Zanchetti | first5 = A. | last6 = Böhm | first6 = M. | last7 = Christiaens | first7 = T. | last8 = Cifkova | first8 = R. | last9 = De Backer | first9 = G. | title = 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. | journal = J Hypertens | volume = 31 | issue = 10 | pages = 1925-38 | month = Oct | year = 2013 | doi = 10.1097/HJH.0b013e328364ca4c | PMID = 24107724 }}</ref><ref name="Chobanian-2003">{{Cite journal | last1 = Chobanian | first1 = AV. | last2 = Bakris | first2 = GL. | last3 = Black | first3 = HR. | last4 = Cushman | first4 = WC. | last5 = Green | first5 = LA. | last6 = Izzo | first6 = JL. | last7 = Jones | first7 = DW. | last8 = Materson | first8 = BJ. | last9 = Oparil | first9 = S. | title = The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. | journal = JAMA | volume = 289 | issue = 19 | pages = 2560-72 | month = May | year = 2003 | doi = 10.1001/jama.289.19.2560 | PMID = 12748199 }}</ref> | ||
===Prehypertension=== | ===Prehypertension=== |
Revision as of 20:58, 22 April 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]
Hypertension Resident Survival Guide Microchapters |
---|
Overview |
Classification |
Causes |
Diagnosis |
Treatment |
Medications |
Do's |
Don'ts |
Overview
Classification
Classification | Blood pressure (mmHg) |
---|---|
Normal | < 120/80 |
Prehypertension | 120-139/80-89 |
Stage 1 hypertension | 140-159/90-99 |
Stage 2 hypertension | ≥ 160/110 |
Isolated systolic hypertension | |
Isolated diastolic hypertension |
Causes
Life Threatening Causes
Common Causes
Diagnosis
Shown below is an algorithm summarizing the diagnosis of hypertension based on the seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and 2013 ESH/ESC guidelines for the management of arterial hypertension.[1][2]
General Approach
Suspected hypertension BP > 140/90 mmHg | |||||||||||||||||||||||||||||||||||||||||
Blood pressure measurement Before taking the BP
❑ Take 2 readings and find the average Click here for more information regarding blood pressure measurement | |||||||||||||||||||||||||||||||||||||||||
Office BP >140/90 mmHg on 2-3 visits | |||||||||||||||||||||||||||||||||||||||||
Does the patient have any evidence of target organ damage, DM, or CKD? | |||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||
Proceed to hypertensive crisis resident survival guide | Perform home BP/out-of-office monitoring | ||||||||||||||||||||||||||||||||||||||||
Is the average home BP measurement <140/90? | |||||||||||||||||||||||||||||||||||||||||
Yes | Inconclusive | No | |||||||||||||||||||||||||||||||||||||||
Perform 24-hour ABPM | |||||||||||||||||||||||||||||||||||||||||
Is the 24-hour ABPM ≤135/85? | |||||||||||||||||||||||||||||||||||||||||
White-coat hypertension confirmed | Yes | No | Hypertension confirmed | ||||||||||||||||||||||||||||||||||||||
❑ Continue BP monitoring ❑ Follow-up appointment in .... | Classify the patient based on the BP reading | ||||||||||||||||||||||||||||||||||||||||
SBP 120-139 mmHg DBP - 80-89 mmHg | SBP 149-159 mmHg DBP 90-99 mmHg | SBP >160 mmHg DBP >110 mmHg | |||||||||||||||||||||||||||||||||||||||
Prehypertension | Stage 1 hypertension Proceed to the complete diagnostic approach | Stage 2 hypertension
Proceed to hypertensive crisis resident survival guide | |||||||||||||||||||||||||||||||||||||||
Determine who to treat based on the following: | |||||||||||||||||||||||||||||||||||||||||
Complete Diagnostic Approach
Obtain a detailed history: History of present hypertension
❑ Excessive sodium intake >2.4g per day ❑ Eyes:
❑ Cardiovascular:
❑ Kidneys:
| |||||||||||||||||||
Examine the patient: General examination: Neck
Respiratory examination Abdominal examination
| |||||||||||||||||||
Order tests: Routine
❑ Serum calcium
Additional tests based on results of the routine tests above:
❑ 24-hour free urinary cortisol (elevated in Cushing's syndrome)
❑ Chest CT angiography (To evaluate aortic coarctation) | |||||||||||||||||||
Does this patient have an identifiable secondary etiology? | |||||||||||||||||||
Yes | No | ||||||||||||||||||
Primary hypertension | Secondary hypertension | ||||||||||||||||||
Proceed to treatment | |||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of hypertension based on the 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8), ESH/ESC guidelines for the management of arterial hypertension, and the seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.[3][1][2]
Prehypertension
Stage 1 Hypertension
Determine who to treat: ❑ BP ≥ 150/90 mmHg in patients ≥ 60 years | |||||||||||||||||||||||||||||
Review BP goals: General population | |||||||||||||||||||||||||||||
Initiate lifestyle modification: ❑ Weight reduction
❑ Adopt healthy diet
❑ Limit alcohol consumption
❑ Regular aerobic physical activity (brisk walking, jogging, cycling, swimming) for at least 30 mins per day | |||||||||||||||||||||||||||||
Does the patient have DM or CKD? | |||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||
CKD ± DM | DM only | ||||||||||||||||||||||||||||
Consider the race of the patient | |||||||||||||||||||||||||||||
Black population | Non-black population | ||||||||||||||||||||||||||||
Initiate: ❑ ACE inhibitors alone, OR | Initiate: ❑ Thiazide-type diuretic alone, OR | Initiate: ❑ Thiazide-type diuretic alone, OR | |||||||||||||||||||||||||||
Has the target BP been reached? | |||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||
Consider the following: ❑ | |||||||||||||||||||||||||||||
Monitoring and follow-up: ❑ | |||||||||||||||||||||||||||||
Medications
Drug Class | Drug | Initial daily dose, target dose (mg) |
---|---|---|
Thiazide diuretics | Chlorthalidone | 12.5, 12.5-25 |
Hydrochlorothiazide | 12.5-25, 25-100 | |
Bendroflumethiazide | 5, 10 | |
Indapamide | 1.25, 1.25-2.5 | |
ACE inhibitors | Enalapril | 5, 20 |
Lisinopril | 10, 40 | |
Captopril | 50, 150-200 | |
ARBs | Candesartan | 4, 12-32 |
Losartan | 50, 100 | |
Valsartan | 40-80, 160-320 | |
Eprosartan | 400, 600-800 | |
Irbesartan | 75, 300 | |
Beta blockers | Atenolol | 25-50, 100 |
Metoprolol succinate | 50, 100-200 | |
Calcium channel blockers | Amlodipine | 2.5, 10 |
Diltiazem extended release | 120-180, 360 | |
Nitrendipine | 10, 20 |
Do's
Don'ts
References
- ↑ 1.0 1.1 Mancia, G.; Fagard, R.; Narkiewicz, K.; Redán, J.; Zanchetti, A.; Böhm, M.; Christiaens, T.; Cifkova, R.; De Backer, G. (2013). "2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension". J Hypertens. 31 (10): 1925–38. doi:10.1097/HJH.0b013e328364ca4c. PMID 24107724. Unknown parameter
|month=
ignored (help) - ↑ 2.0 2.1 Chobanian, AV.; Bakris, GL.; Black, HR.; Cushman, WC.; Green, LA.; Izzo, JL.; Jones, DW.; Materson, BJ.; Oparil, S. (2003). "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure". Hypertension. 42 (6): 1206–52. doi:10.1161/01.HYP.0000107251.49515.c2. PMID 14656957. Unknown parameter
|month=
ignored (help) - ↑ Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL; et al. (2003). "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure". Hypertension. 42 (6): 1206–52. doi:10.1161/01.HYP.0000107251.49515.c2. PMID 14656957.